U.S. Markets open in 50 hrs, 25 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.73 04:00 PM EDT | |
|---|---|---|
| Day High | 1.85 09:30 AM EDT |
|
| Range | 0.12 |
| Volume | 313,406 | |
|---|---|---|
| 30-Day Avg Vol | 668,000 |
|
| Difference | -53.08% |
| Market Cap | 49.98 M | |
|---|---|---|
| Mkt Cap Chg | -3.46 M |
| Shares Out | 28.89 M | |
|---|---|---|
| % Shrs Traded | 1.08% | |
| 1yr EPS Est | -0.965 |
| 52-Wk Low | 1.50 12/31/08 | |
|---|---|---|
| 52-Wk High | 8.43 2/20/09 |
|
| Range | 6.93 |
| Prev Close | 1.85 7/1/09 | |
|---|---|---|
| Today's Open | 1.85 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 745,402.00 |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -32.40 M | |
| Earnings (MRQ) | -8.76 M | |
| Next Earn Est | -0.28 | |
| Next Earnings | 10/22/2009 |
|
| EPS (TTM) | -1.17 | |
| 1yr EPS Growth | 17.52% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -1.00 | |
| PEG Ratio | — | |
| Return on Equity | -79.68 | |
| Beta | -1.09 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Anadys Pharmaceuticals has hepatitis and cancer in the crosshairs. The biotechnology company is developing new therapeutic treatments for those infected with hepatitis C (HCV) and other bacterial infections, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.28 7/23/09 | — — |
—
—
|
| Last Quarter | -0.307 3/31/09 | -0.30 3/31/09 |
0.007
Beat
|
| 2 Quarters Ago | -0.328 12/31/08 | -0.30 12/31/08 |
0.028
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -276,000.00 | -1.14 M |
| Operating Income | -8.93 M | -34.10 M |
| Net Income | -8.76 M | -32.40 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts